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Modern imaging techniques allow for the noninvasive diagnosis of endometriosis. Preoperative staging of pelvic
endometriosis helps the gynecologist plan therapy and offer a prognosis to patients. The challenge of creating
a satisfactory classification of endometriosis remains. The ability of the current classification schemes to predict
pregnancy outcome, or aid in the management of pelvic pain, is recognized to be inadequate. The study of deeply
infiltrating endometriosis and adenomyosis is greatly hampered by a lack of clear terminology and the absence of
a consensus classification of the lesions. A reviewed consensus classification of endometriosis in general, with a
more detailed consideration on deep endometriosis, is urgently required. We suggest a new staging system for deep,
infiltrating endometriosis based on ultrasonographic findings. Prospective data collection and review in large centers
may provide a larger clinical base from which to derive empirical point scores and breakpoints in the classification
scheme.
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Introduction
Endometriosis is a benign gynecological disease de-
fined as the presence of endometrial glands and
stroma outside of the uterine cavity. It affects 5–
10% of women of reproductive age and produces
symptoms including dysmenorrhea, deep dyspare-
unia, and chronic pelvic pain.1
Although endometriosis represents one of the
most studied gynecological conditions, it still re-
mains an enigmatic disease, difficult both to study
and to understand. A part of the clinical confu-
sion, and inappropriate management surrounding
endometriosis, comes from the variability of its clin-
ical presentation, the variable aspect of the lesions,
and from its multifocal distribution. Furthermore,
the lack of clear terminology and the absence of
a consensus on a preoperative staging system can
lead to misunderstandings when trying to compare
results and outcomes.
Endometriosis: a multiform disease
Threedifferent formsof endometriosismust be con-
sidered: peritoneal, ovarian, and deep infiltrating
endometriosis (DIE).2 The presence of endome-
trial glands and stroma within the myometrium
characterize another form of endometriosis called
adenomyosis. In this case, microscopically, there
are endometrial glands and stroma within the my-
ometrium.
In detail, superficial peritoneal endometriosis has
multiple types of appearance. The typical lesion
has a puckered, blue-black, powder-burned appear-
ance. Others appear as atypical lesions, including
themicroscopic, early, or subtle (papular or glandu-
lar; vesicular), hemorrhagic (red vesicular or flame-
like), and fibrotic (from white to black pigmented)
lesions, supposedly representing the evolution of a
superficial implant.3,4
Ovarian endometrioma is also called a “chocolate
cyst” because of the characteristic dark brown or
chocolate-colored content.5 It can be monolateral
or bilateral. When only one ovary is affected, the
preferential site is the left ovary.3
DIE is a specific entity histologically definedwhen
endometriotic lesions extend more than 5 mm un-
derneath the peritoneum.6,7 DIE is responsible for
painful symptoms, the severity of which are strongly
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associated with the depth of the lesions.8–10 Another
aspect of deeply infiltrating endometriosis lesions is
their multifocal character. In a group of 241 pa-
tients, 344 lesions were histologically determined as
DIE. The percentage of lesions located on a single
organ (uterosacral ligaments, upper portion of the
posterior vaginawall, bladder, and intestine) ranged
between 29% and 83%.11
Because of the different locations, possi-
ble origins, types of appearance, and hormone
responsiveness, it has been recently suggested that
peritoneal endometriosis, ovarian endometriosis,
DIE, and adenomyosis are different entities—each
possibly with a different pathogenesis.12,13
Peritoneal endometriosis is thought tobe the con-
sequence of the implantation of menstrual laboring
after reflux through the fallopian tube and ovar-
ian endometrioma, and through the consequence
of nonhormone-regulated bleeding from intraovar-
ian epithelial inclusions after they have undergone
metaplasia into endometrial-like tissue.5
The pathogenesis of DIE is the most debated. Ac-
cording to some investigators, its histopathogenesis
is probably not related to the implantation of en-
dometrial cells deriving from retrograde menstru-
ation, but rather to the metaplasia of Mu¨llerian
rests. Recently, Chapron14 observed that pelvic
DIE lesions are more frequently observed in the
posterior pelvic compartment and are most often
located on the left side. Furthermore, abdominal
DIE lesions are far less frequent than pelvic DIE
lesions and, unlike these, they are most often lo-
cated in the right side of the abdominal cavity
(appendix and ileocecum junction). The author
concluded that these observationsmay be also in fa-
vor of the theory of retrogrademenstruation forDIE
lesions.14
Current staging systems for endometriosis
Endometriosismaypresent itself inmany forms, but
for clinical and research purposes it can be classified
as peritoneal, ovarian, or deep endometriosis. The
extent of the disease varies from a few small lesions
on the peritoneum to extensive fibrosis and adhe-
sion formation, often causing marked distortion of
pelvic anatomy. We cannot forget this principle of
histopathology when classifying the disease.
Currently, the revised scoring systemof theAmer-
ican Society for Reproductive Medicine (rASRM) is
used to determine the disease stage (ranging from
I, indicating minimal disease, to IV, indicating se-
vere disease) on the basis of the type, location, ap-
pearance and depth of invasion of the lesions, and
the extent of the disease and adhesions.15,16 Despite
the revisions, the rASRM system has serious limita-
tions, including poor correlation with severity and
poor prognostic valuation of the response to thera-
pies for pain or infertility.16 Moreover, as a surgical
staging system, it implies the necessity of a surgical
approach.
Visualization at surgery, mainly through la-
paroscopy, is still regarded as the gold standard diag-
nostic test—the definitive method to diagnose and
stage endometriosis when looking for evidence of
all types and stages of endometriosis. On the other
hand, surgery performed in order to verify the pres-
ence of endometriosis or adhesions and to stage the
disease, might imply high health costs and surgery
risks for patients.
Staging deep endometriosis
Another limitation of the rASRM system is the lack
of specific in addressing the infiltrative form of en-
dometriosis. In the rASRM staging system, great
importance is given to ovarian endometriomas. But
from a practical point of view, surgery for these
conditions is not a complex procedure and does not
require particularly experienced and expertly skilled
surgeons, nor a multidisciplinary approach.17
Several schemes have been proposed to classify
endometriosis with deep infiltrating lesions. Kon-
inckx and Martin’s scheme was essentially based on
the pathogenesis of DIE [infiltration (Type 1), re-
traction (Type 2), and adenomyosis externa (Type
3)].18 Adamyan proposed a staging system with
retrocervical endometriosis according to the ex-
tent of the disease: Stage I with no vaginal involve-
ment, Stage II involves the vagina, Stage III involves
the vagina and rectum and has cul-de-sac distor-
tion, andStage IV includes cul-de-sac obliteration.19
The Martin and Batt staging system also takes the
DIE lesions’ topography into account, differentiat-
ing among retrocervical, rectovaginal pouch, and
rectovaginal septum endometriosis.20 As Chapron
observed, these staging systems are essentially lim-
ited by two factors. They do not consider the pos-
sibility of associated anterior disease (bladder DIE)
in cases of posterior DIE; additionally, they group
together patients for whom the surgical treatment
may be very different.11
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More recent staging systems try to correct these
limitations. Chapron et al. suggest a classification
essentially based on the DIE anatomic distribution
and surgical management.11 They take into account
the presence of lesions in both antero- and poster-
outerine pouches.11 Finally, in the ENZIAN-Score,
four different stages are pronounced in analogy to
an oncological staging, especially focusing on the
retroperitoneal part of the severe endometriosis.21
Nevertheless, these staging systems based on sur-
gical approaches, do not take into account symp-
toms of patients, do not specify the size and shape
of the lesions, and are not suitable for a follow-up
of patients when a conservative/expectant course of
management is decided. Thus, the challenge of cre-
ating a satisfactory classification of endometriosis,
and namely of DIE, remains.
As Vercellini observed, a valid and reliable clas-
sification should allow immediate comprehension
of the severity of the condition, guide therapeu-
tic strategies, permit the formulation of a reliable
prognosis, and represent a feasible tool for research
purpose.17
A number of important motivations are at the
basis of the necessity for an ultrasonographic stage
system of endometriosis:
• to map distribution of the lesions;
• to informthepatientof the therapeuticoptions
and the prognosis;
• to allow correct planningof the therapeutic ap-
proach and facilitate choosing between several
treatment options, medical, and surgical;
• to produce a standardized method and lan-
guage for scientific groups studying en-
dometriosis; and
• to allow comparisons of results.
In cases of expectant/medical management:
• to facilitate follow-up of the lesions; and
• to evaluate efficacy of medical treatment in re-
ducing painful symptoms.
In the preoperative evaluation:
• to correctly identify different locations of en-
dometriosis in certain sites, such as intestine or
bladder where the surgery is particularly diffi-
cult and risky, thus requiring the cooperation
of different specialists (multidisciplinary ap-
proach);
• to select an appropriate surgeon with sufficient
experience in this kind of surgery; and
• to counsel the patient about the risks of surgery.
Imaging methods
Modern imaging techniques allow noninvasive di-
agnosis of endometriosis. Ultrasound is gener-
ally considered a noninvasive, reproducible, and
cost/effective method.
An ovarian endometrioma is described with
imaging as a persistent, circular, homogeneous, hy-
poechoic “tissue,” without papillary proliferations,
and with a clear demarcation from the ovarian
parenchyma.22–27 Deep endometriosis implants are
suspected from the presence of hypoechoic linear
thickening or nodules/masses, with or without reg-
ular contours, that have thin band-like echoes de-
parting from the center of the mass defined as an
“Indian head dress” (Fig. 1).28,29
Many studies have validated the nonsurgi-
cal diagnosis of endometriomas and deep en-
dometriosis through transvaginal ultrasonography
(TV-US).22–29 Specifically, investigators have ob-
served a sensitivity of 81–89% and specificity of
91–97% in predicting the endometriotic nature of
ovarian cysts.30 With regard to deep endometriosis,
Guerriero et al. observed a high specificity and sen-
sitivity in the detection of vaginal wall lesions (sen-
sitivity of 91%, specificity of 89%) and rectovagi-
nal endometriosis (sensitivity of 74%, specificity of
88%). For other locations, the sensitivity was lower
(ranging from 67% to 33%) but with a comparable
specificity.29,31
Recent technology offers interesting new proce-
dures, such as 3-dimensional sonography, that could
integrate 2-dimensional sonography and increase
its diagnostic accuracy in the assessment of deep
endometriosis. As suggested by Guerriero et al.,
in the near future, 3-dimensional sonography for
DIE could be an interesting mode of research
with positive effects in everyday clinical practice.32
Dessole et al. suggested “sonovaginography” as a
new technique for the assessment of rectovaginal
endometriosis. It is based onTV-US, combinedwith
the introduction of saline solution into the vagina
that creates an acoustic window between the probe
and the surrounding structures of the vagina.33 Re-
cently Guerriero et al. have created “tenderness-
guided” ultrasonography by increasing the amount
of ultrasound gel inside the probe cover. Moreover,
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Figure 1. Abnormal hypoechoic implant of deep endometriosis with irregular contours.
they asked patients to indicate which points felt ten-
der under gentle pressure of the probe. Using this
approach, they obtained a specificity of 95% with a
sensitivity of 90%.29 Locations above the rectosig-
moid junction may be beyond the field of view of
a transvaginal approach and limited by the pres-
ence of air for the transabdominal approach. These
cases would require magnetic resonance imaging
(MRI).34
Nonsurgical diagnostic approaches, such as TV-
US and MRI, perform poorly in the detection of
peritoneal and ovarian implants.3 This group of
patients often has less severe symptoms and has
little risk of developing serious associated prob-
lems. Because the clinical significance of minimal
endometriosis is not thoroughly defined, it is un-
certain by which means, if at all, such types of peri-
toneal or ovarian lesions should be treated. It is still
uncertainwhether some early forms of endometrio-
sis (rASRM I and II) may represent a physiological
condition and thus should not be considered a dis-
ease.35
What we retain to be the most urgent criterion
is a tool to study endometriosis, at the time of the
first diagnosis, that is able to allow the gynecologist
to discuss the various options of treatment with




Currently, transvaginal ultrasound is involved in
the diagnosis and workup of endometriosis. Its
widespread use, the low invasivity, the reduced
cost, and the high specificity and sensitivity make
transvaginal sonography afirst-level test in the study
of endometriosis.
We propose a new staging system based on ul-
trasonographic findings. Our goal was to develop a
feasible and reproducible clinical tool, to map and
describe deep endometriotic implants, and to allow
follow-up in cases of conservative management.
This classification is based on the evaluation of
five components of DIE implants: location, size,
shape of the lesions, symptoms aroused during the
exam, and infiltration of the bowel wall. Adjunctive
elements are also evaluated (e.g., presence of mono-
lateral or bilateral ovarian endometrioma, kissing
ovaries, adenomyosis, fixity of organs, and the uri-
nary tract; Fig. 2). The staging system requires a de-
tailed ultrasonographic examination protocol that
includes, in addition to routine analysis of the uterus
and ovaries, analysis of the vesicouterine pouch and
the pouch of Douglas, the bowel (rectum, sigmoid
colon, appendix, cecum, and small intestine), the
retrocervical area (uterosacral ligaments, torus uter-
inus, and posterior vaginal fornix), and the recto-
vaginal septum.
Themultifocal character of deeply infiltrating en-
dometriosis lesions has prompted us to propose an
“ultrasonographic classification” based firstly on the
location of the lesions. Lesions observed can involve
the anterior, posterior, or lateral compartments. The
cervixof theuterus is a structure that is easy to recog-
nize during TV-US. Thus, the distribution of lesions
is described inmore detail by specifying the position
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in relation to the cervix: sopracervical, cervical, or
vaginal.
For each location, lesions are described as nod-
ules (solid hypoechoic nodule with a rounded
shape), linear thickening (abnormal hypoechoic lin-
ear thickening), or plaques (hypoechoic areas with
irregular shape). The maximum longitudinal, an-
teroposterior, and transversal axes of the implants
are also measured. In our classification scheme,
painful symptoms, aroused during the exam by
gently pushing the probe on each lesion, are reg-
istered on the basis of a numerical rating scale:
none (0), mild (1–3), moderate (4–6), and severe
(7–10).
Bowel involvement is suspected when a long,
nodular, predominantly solid, hypoechogenic le-
sion adhering to the wall of the intestinal loop is
observed. The degree of infiltration may vary from
the serosal layer as far as the mucosal layer. Bazot
et al. suggested that TV-US can accurately diagnose
colorectal endometriosis and identify the infiltra-
tion of the muscolaris propria.28 All the layers of
the bowel wall should be observed from the outer
toward the inner layers: the serosa (thin hypere-
choic line); themuscularis propria (two hypoechoic
strips separated by a fine hyperechoic line); the sub-
mucosa (hyperechoic); the muscularis mucosa (hy-
poechoic); and the interface between the lumen and
the mucosal layer (hyperechoic).36
Bazot’s results were not, however, confirmed in
larger studies. Thus, other techniques often are em-
ployed to specify the degree of bowel infiltration, for
example, TV-US with bowel preparation (TVUS-
BP),36 transrectal ultrasonography,37,38 endoscopic
transrectal ultrasonography,28,39 TV-US combined
with water-contrast in the rectum (RWC-TVS),40
andmultislice computerized tomography combined
with the distension of the colon by rectal entero-
clysis.41 In these cases, supplementary procedures
should always be specified.
Adjunctive elements are added on a separate
section: ovarian endometrioma(s), kissing ovaries,
ovarian fixity, adenomyosis (diffuse or nodular), or
urinary tract evaluation. The detection of kissing
ovaries at ultrasound, when the ovaries are entirely
or partly joined together and stabilized behind the
pouch of Douglas, seems strongly associated with
the presence of endometriosis, and is a marker of
the most severe form of this disease.42 Ovarian fix-
ity was assessed by abdominal pressure with the ex-
aminer’s hand and gentle pressure with the vaginal
probe. In our experience, TV-US performed in the
presence of fluid in the pelvis may show better ad-
hesions attached to the uterus and ovaries. During
TV-US, the absence of sliding of surrounding tis-
sues and, in presence of pelvic fluid, the absence
ballottement are suggestive for ovarian adhesions.
In our classification, two levels were distinguished:
absence of adhesions, if the ovary is completely free
and could be observed sliding across the surround-
ing tissues; and presence of adhesions, when someof
the surrounding structures could not be separated
from the ovary.
New application and future perspectives
In the management of endometriosis, a reviewed
consensus classification of the disease in general,
with a more detailed attention to deep endometrio-
sis, is urgently required. One of the principal
challenges actually involved in managing en-
dometriosis is obtaining information that might
help the decision-making process and allow the gy-
necologist to select the optimal surgical strategy,
evenbefore the surgery.36,43 In cases ofDIE, themost
symptomatic form of the disease, often requiring
more complex surgical treatment, this information
assumes particular weight.36
The ideal situation is to receive complete treat-
ment in a single operation. As the effectiveness of
surgery depends on how radical exeresis is, the sur-
geon should be aware of the location of DIE and
plan the operative technique accordingly.11 Thus,
when deep endometriosis is clinically suspected, it
is fundamental to perform an adequate preopera-
tive workup capable of indicating whether one or
more lesions are present, mapping the lesions, and
identifying the size and depth of the lesion(s), and
the involvement of surrounding tissue.With this in-
formation, it is then possible to define the treatment
option to be applied, to devise a comprehensive sur-
gical plan, and to coordinate different surgical pro-
cedures when necessary.36
Moreover, the lack of appropriate noninvasive
tools is currently the main limitation for monitor-
ing the disease progression, predicting clinical out-
comes, and evaluating therapeutic effects evenwhen
medical/expectant management has been decided.
A recent review showed that medical treatment in
women with rectovaginal endometriosis was effec-
tive in terms of pain relief, lesion reduction during
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Figure 2. “Deep endometriosis staging” form.
therapy, and improvement in health-related quality
of life.44 The incessant progress in production of
new pharmaceuticals creates an enormous need for
noninvasive diagnostics of endometriosis.
In light of this, a standard ultrasound mapping
technique may develop into a very promising tool
for a noninvasive, reproducible, and feasible staging
system in the future.
Some limitationsof this classification systemneed
to be identified. For example, if there are multiple
lesions at a given site, it might be difficult to assess
which of the lesions is responsible for causing pain
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Figure 2. Continued
during examination, the perception of pain might
vary significantly from individual to individual and
in the same patient across different examinations.
Moreover, the examiner might apply a pressure of
different intensity. Regarding the evaluation of pain,
our group tried applying the “tenderness-guided”
TV-US suggestedbyGuerriero et al. as anewmethod
for the detection of deep endometriosis.29 Patients
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were asked to indicate during the ultrasonographic
examination which points felt tender under gen-
tle pressure of the probe, and examiners paid par-
ticular attention to evaluate those sites. Moreover,
the same investigators observed that this technique
showed high specificity and sensitivity in the de-
tection of vaginal and rectovaginal endometriosis.
Good specificity associated with lower sensitivity
was obtained in the diagnosis of deep endometrio-
sis of uterosacral ligaments, rectosigmoid involve-
men, and anterior deep endometriosis.29 Notwith-
standing these limitations, in our experience,
evaluation of pain aroused during TV-US exam-
ination in the different compartments (anterior,
posterior, and lateral) before and after treatment
is useful for clinically assessing how intensely pa-
tients are feeling pain and for monitoring the effec-
tiveness of treatments in time. As pain is a subjec-
tive experience, self-reported pain scores are used
widely in clinical and research settings; the numeric
rating scale has shownhigh accuracy for quantifying
a patient’s subjective pain.45
Our proposal is intended to provide a basis for fu-
ture developments. Prospective data collection and
review in large centers may provide a larger clinical
base from which to derive empirical point scores
and breakpoints in the classification scheme. As
with any new examination, there will be a sub-
stantial learning curve with TV-US mapping, and
intraobserver and interobserver variability should
be evaluated. The results of further studies will
determine whether preoperative ultrasonography
mapping can lead to a decrease in the number of
surgical procedures needed, in a change of the sur-
gical procedure planned, in a more complete ex-
eresis, and reduction of recurrences and of surgical
complications.
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